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Abstract
Aims: Elevated dynamic plantar pressures are a consistent finding in diabetes patients with peripheral neuropathy with
implications for plantar foot ulceration. This meta-analysis aimed to compare the plantar pressures of diabetes patients that
had peripheral neuropathy and those with neuropathy with active or previous foot ulcers.
Methods: Published articles were identified from Medline via OVID, CINAHL, SCOPUS, INFORMIT, Cochrane Central EMBASE
via OVID and Web of Science via ISI Web of Knowledge bibliographic databases. Observational studies reporting barefoot
dynamic plantar pressure in adults with diabetic peripheral neuropathy, where at least one group had a history of plantar
foot ulcers were included. Interventional studies, shod plantar pressure studies and studies not published in English were
excluded. Overall mean peak plantar pressure (MPP) and pressure time integral (PTI) were primary outcomes. The six
secondary outcomes were MPP and PTI at the rear foot, mid foot and fore foot. The protocol of the meta-analysis was
published with PROPSERO, (registration number CRD42013004310).
Results: Eight observational studies were included. Overall MPP and PTI were greater in diabetic peripheral neuropathy
patients with foot ulceration compared to those without ulceration (standardised mean difference 0.551, 95% CI 0.290–
0.811, p,0.001; and 0.762, 95% CI 0.303–1.221, p = 0.001, respectively). Sub-group analyses demonstrated no significant
difference in MPP for those with neuropathy with active ulceration compared to those without ulcers. A significant
difference in MPP was found for those with neuropathy with a past history of ulceration compared to those without ulcers;
(0.467, 95% CI 0.181– 0.753, p = 0.001). Statistical heterogeneity between studies was moderate.
Conclusions: Plantar pressures appear to be significantly higher in patients with diabetic peripheral neuropathy with a
history of foot ulceration compared to those with diabetic neuropathy without a history of ulceration. More homogenous
data is needed to confirm these findings.
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Introduction
One of the most detrimental complications of both Type 1 and
Type 2 diabetes mellitus (DM) is foot ulceration [1,2]. The
prevalence of diabetes foot ulceration (DFU) in the United States
ranges between 4 and 12%, the annual incidence ranges between
1 and 4.1% and the lifetime incidence can be as high as 25% [3].
DFU is caused by the interplay of several factors, but most notably
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diabetic peripheral neuropathy (DPN), peripheral arterial disease
(PAD) and changes in foot structure, resulting in foot deformity
and increased weight bearing pressure [4–6].
DFU proceeds up to 85% of all amputations in DM patients
and the estimated likelihood of lower limb amputation is 10 to 30
times higher amongst patients with DM, compared to non-DM
counterparts [3,8]. Substantial healthcare costs are associated with
foot ulcer treatment and prevention in both developed and
developing countries and this is a global concern [7,9]. Foot
ulceration together with underlying disease processes such as
cardiovascular disease impacts on health related quality of life and
ambulatory status in people with DM, promoting decline in
general health, mental health, physical and social functioning
[7,10,11]. Therefore, greater understanding of the factors precip-
itating DFU is urgently needed.
Raised dynamic plantar pressures are a frequent finding in DM
patients with neuropathy [12–14]. Two measures of vertical
plantar pressure are most commonly assessed. Mean peak plantar
pressure (MPP) represents the maximum amount of pressure
during stance and the mean pressure time integral (PTI) represents
the amount of time over which maximum pressure is applied [15].
A recent meta-analysis of observational studies by our team
demonstrated significantly higher PTI and MPP in DPN patients
when compared to healthy and DM controls that did not have
neuropathy [16].
There has been extensive interest regarding the role of plantar
pressures and pressure offloading in foot ulceration and the ability
to determine a plantar pressure cut-off which predicts ulceration
[17–26]. Several observational studies have investigated the
feasibility of using plantar pressure in identifying those at risk of
ulceration, but the reported sensitivities and specificities are below
those which are typically accepted for a diagnostic test [23,24,25].
Nevertheless, if patients with warning signs of impending foot
ulceration could be identified using plantar pressures, alongside
other confirmed risk factors; it is possible that clinical management
could be improved to avoid foot ulcer development.
Prior to assessing plantar pressure as a screening tool for
ulceration, it would appear necessary to determine whether
plantar pressures are actually significantly higher in patients with
DPN with previous and/or present diabetes foot ulceration
(PPDFU) compared to patients with DPN without a history of
DFU. The relatively low specificity and sensitivity values obtained
in the aforementioned studies raises the question as to whether
there is an increase in plantar pressure prior to the onset of
ulceration and following ulceration in those with DPN. To the best
of the authors’ knowledge a meta-analysis to examine these
questions has not been previously published.
The primary aim of this meta-analysis was to compare plantar
pressures in patients with PPDFU (cases) and individuals with
DPN without a history of ulceration (controls). The secondary
aims were to assess the quality of studies investigating plantar
pressure and to investigate plantar pressure in patients with active
and past ulcers.
Methods
Search strategy and quality assessment
A comprehensive search strategy was utilised, involving MeSH
and Emtree terms and relevant keywords for search strings (see
Figure S1). The databases searched were Medline via OVID (1946
to present), CINAHL (1994–2012), SCOPUS (all years to present),
INFORMIT, Cochrane Central (latest), EMBASE via OVID
(1980 to present) and Web of Science via ISI Web of Knowledge
(1965 to present). One author (MF) and a librarian carried out the
searches (using the same search string) independently on two
separate occasions in November 2012 to identify all relevant
studies published until 18th November 2012. Furthermore, a
repeated search was conducted in February 2014 to identify recent
studies of interest for inclusion. No new articles of relevance were
found after the latter search.
It has been identified that a single candidate tool for the quality
assessment of observational studies does not exist [27]. Assessment
of risk of bias was conducted using a quality assessment tool
adapted from validated instruments (Pedro and CASP) with the
addition of content specific questions concerning plantar pressure
and foot ulceration [28–30]. Risk of bias was assessed by two
blinded authors (PL and EP) who were given study manuscripts
after the removal of author, institutional, title and re-identifiable
information. The quality scores were then checked by one author
(MF) for consistency. Where major differences in quality scores
existed, these were discussed amongst a second group of authors
(MF, MC and PB) and the original blinded quality assessors were
asked to independently review any major differences in ratings.
The quality assessment tool was trialled by the two assessors prior
to use in the meta-analysis. An abbreviated version of the quality
assessment tool used is shown in Table S1 in File S1. As an
adapted quality assessment tool was used a total score of 50 was
possible for the 25 questions. Quality scores of $45, 30–45, 20–30
and #20 were defined as excellent, good, fair and poor
respectively.
Study selection
Studies were included in the meta-analysis if they met all the
below inclusion criteria:
N An observational study;
N Subjects included were adults aged 18 years and over;
N The study was reported in or available in the English language;
N The study used a validated method of diagnosing DPN,
including one or more of the following methods; A screening
questionnaire to assess DPN; 10 g monofilament perception
testing; vibration perception threshold; and nerve conduction
studies;
N Plantar pressures were reported in two groups of subjects with
documented DPN in which at least one group had a previous
or active plantar neuropathic foot ulcer;
N Barefoot dynamic plantar pressure during walking was
reported without the influence of an offloading intervention
or footwear.
N Plantar pressure values were reported as either MPP and/or
PTI in any acceptable pressure unit (KPa, N/kg2 or similar);
N Overall, fore foot, mid foot and/or rear foot MPP or PTI were
reported; Studies were excluded if meeting any of the below
criteria:
N The study was an interventional study. The authors considered
interventional studies utilising offloading options (such as foot
wear, insoles and orthoses) and or/treatment options (such as
podiatry treatment, debridement of callus) as well as the
assessment of plantar pressure could potentially alter the
natural gait cycle and plantar pressures, and thus were
excluded;
N The study did not document DPN status or where all the
participants in a single group did not have documented DPN;
N Data could not be extracted for the two groups of interest or
computed, or where authors were unable to provide data for
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the two groups of interest from a larger dataset when
requested;
N Only in shoe plantar pressure were reported, as these were
considered interventional assessments and the combination of
shod and barefoot findings can drastically increase the
variability of plantar pressure results [26];
N Full text manuscripts could not be acquired.
The two primary outcomes of this study were overall MPP and
overall mean PTI. The six secondary outcomes were MPP at the
rear foot, MPP at the mid foot, MPP at the fore foot, PTI at the
rear foot, PTI at the mid foot and PTI at the fore foot.
Potential studies identified for inclusion were reviewed inde-
pendently by 3 authors (MF, RC and MC) using the above
inclusion criteria. Where there was disagreement in the inclusion
of studies, group discussions were held to resolve any differences in
opinion. All reference lists of studies meeting the inclusion criteria
were browsed for any additional studies for inclusion. Authors of
the included studies were likewise contacted via email for
identification of other potential studies for inclusion. No further
studies of relevance were found.
Data extraction and synthesis
Data extraction was completed by the primary author, using
specifically developed data extraction forms. The forms were then
checked by two authors (EP and PL) for any omissions. Descriptive
data, such as age, gender, body mass index (BMI), and disease
specific data, such as DM duration, type of DM, HbA1c, degree of
neuropathy, presence of PAD, and presence of foot deformity were
extracted from each study for comparison. Numerical data (mean
and standard deviation [SD]) for each plantar pressure variable
(MPP and/or PTI) were also extracted and included in the
analysis. Where anatomical locations were unspecified, or when
overall MPP was the only variable reported, authors were
contacted for plantar pressure data specific to different plantar
locations.
The MOOSE reporting guidelines for meta-analysis of obser-
vational studies was used in the synthesis of this manuscript [31].
The protocol of the meta-analysis was registered and published
with PROSPERO database of systematic reviews and meta-
analyses prior to completing data extraction (registration number
CRD42013004310). Meta-analysis was attempted where more
than three studies reported a given outcome measure. Random
effects models were used to analyse the studies based on the
prospect there would be between study heterogeneity present.
Statistical methods
Standardised mean differences were used in the computation of
meta-analyses of plantar pressure differences utilising Cohen’s d
[32]. Results were reported as standardised mean differences with
95% confidence intervals (95%-CI) and p-values. Where SD was
not reported, standard error (SE), inter-quartile range (IQR) or
equivalent was converted to SD values. Since both Boulton et al.
and Cavanagh and colleagues [33,34] did not report SD for the
distribution of plantar pressure and were unable to provide
information about SD when contacted, these were estimated using
linear regression of SD on mean values for MPP. However as the
highest reported aggregate plantar pressure was 83.1 N/cm2, these
estimations are approximations only and sensitivity analyses were
conducted excluding these studies. As Stess et al. reported SE [35],
SD was calculated using the formula SE=SD/!n. Similarly, as
Sauseng et al. reported IQR [36], SD was estimated using the
IQR value and PASS statistical software (NCSS LLC; Kaysville
Utah).
Weighted means (according to the sample size of the studies)
were calculated for the reported demographic variables. A
Cohen’s d score of zero was interpreted as no difference in effect;
a result of 0 to 0.2 was interpreted as a small effect, 0.2–0.8 as a
moderate effect and $0.8 as a large effect [37]. All statistical
analyses were carried out by an experienced statistician (PB) using
the software package Comprehensive Meta-Analysis (www.Meta-
Analysis.com, USA).
In order to obtain any missing data or to clarify any
discrepancies in data, several attempts were made to contact the
corresponding authors by email, using open-ended questions.
Where multiple studies were published from the same data set, the
study with the most information reported in relation to the
outcome measures of interest was used. Where more than one
publication reported data from a single study, the publication with
the largest data set was used. The primary unit of analysis for the
meta-analysis was the patient. Where the unit of analysis were feet
instead of patients, caution was taken in the interpretation of the
results and authors were contacted for clarification. Rich et al.
reported findings as number of feet instead of number of patients
and the authors were unable to provide information specific to the
patients [38].
The Q and I2 statistics were used to assess statistical
heterogeneity between studies. I2 values of 25%, 50% and 75%
were acknowledged as low, moderate and high heterogeneity
respectively. In addition to this, the classic fail safe (N) was also
computed; as this gives an estimation of studies needed to be
published with a null effect to renounce the findings from the
meta-analysis [39]. Sub-group analyses and sensitivity analyses
were performed to examine the effect of including and excluding
several studies. Sensitivity and sub-group analyses comprised of:
Analyses including only active foot ulcer patients from the PPDFU
group; analyses including only previous foot ulcer patients from
the PPDFU group; analyses excluding the two studies for which
SD was estimated [33,34]; analyses excluding Rich et al. due to the
difference in unit of analysis [38]; analyses with exclusion of Stess
et al. due to the high level of statistical heterogeneity and the
inclusion of amputees in the study [35]; and separate analyses with
the exclusion of all three studies listed above.
Results
Search Results
The systematic search strategy resulted in the identification of
2730 citations. Figure 1 demonstrates a flow diagram representing
the inclusion and exclusion of studies. The search strategy
identified six studies for inclusion in the meta-analysis. A further
two studies were identified and included after browsing through
the reference lists of the included articles, resulting in a total of
eight observational studies [23,33–36,38,40–41].
Description of studies
A comprehensive list of study characteristics can be found in
Table 1. In total there were 647 DM participants from all eight
studies. This included 238 PPDFU patients. The mean sample size
of the PPDFU groups was 29.7 and ranged from 9 to 70 patients.
The age range of the PPDFU patients was 52.3 to 62.4 years with
a weighted mean age of 56.8 years. The majority of patients
(77.3%) were men. The BMI of this group ranged from 27 Kg/m2
to 30.9 Kg/m2 (weighted mean 30.2 Kg/m2). The weighted mean
duration of DM was 16.4 years with a range of 14.3 to 22.7 years.
Sixty six percent of patients had active foot ulcers at the time of
data collection and the remaining 34% were patients with a
history of foot ulcers. The time period for which ulceration
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occurred varied between studies and most studies failed to report
the time period which had elapsed since the last occurrence of
ulceration in those with a history of ulcers. The monofilament
perception threshold (MPT) was only reported by one study and
was 2.89 [34]. The mean vibration perception threshold (VPT) in
the PPDFU group was 37.6 V with a range of 33.5 to 40 V. Mean
HbA1c was only reported by one study and was 8.8% or
73 mmol/mol [36]. Ankle brachial pressure index (ABPI) was
reported by three studies and the weighted mean ABPI was 1.06
with a range of 0.96 to 1.44 [23,33,35].
The group of DPN patients without a history of foot ulcers
consisted of 409 subjects. The mean sample size was 51.1 with a
range of 9 to 149 patients. Overall the weighted mean age of this
group was 54.7 years with a range of 49.9 to 66 years. The
minority of subjects (49.7%) were men and the BMI range was
26.1 to 32.3 Kg/m2 (weighted mean 31.0 Kg/m2). The weighted
mean DM duration was 12.0 years with a range of 9.2 to 22.1
years. The mean MPT value reported in one study was 1.98 [34].
The weighted mean VPT value was 32.4 V with a range of 28 to
44 V. The mean HbA1c, reported by one study was 8.0%, or
64 mmol/mol [36]. The mean ABPI of this group was 1.04 with a
range of 0.99 to 1.30.
The method of diagnosing DPN varied in different studies. One
study used monofilament testing alone at six plantar locations to
identify DPN [35]. One study used neuropathic symptoms and an
absent ankle reflex for the diagnoses of DPN [33], however, this
was an acceptable means of diagnosing DPN at the time of the
study. A few studies utilised neuropathy questionnaire(s) for the
assessments of DPN, in addition to the VPT [38,40,41]. Only one
study commented on the presence/absence of plantar callus on the
feet of participants. Brash et al. identified the locations of plantar
callus and found no significant difference in callus between the two
groups studied [41].
Risk of bias in included studies
The overall agreement between the two quality assessors was
good; with the range of variation of scores between zero to three
points (Table S1 in File S1). In general, all studies used an
appropriate study design, accounted for potential confounders and
reported data for at least 85% of the participants for a primary
outcome measure. However, four studies failed to discuss the main
sources of bias within the study [33,35,38,41] and two studies did
not identify the presence of PAD or exclude those with PAD
[34,40]. There was not an overall noteworthy difference in the
methodological quality of studies. The highest score for the
method and participant specific questions were given to two
studies which addressed issues such as number of steps used in
measurements, number of walking trials and the measurement of
factors which potentially affected plantar pressure, such as foot
structure [38,40].
Primary outcome measures
Overall MPP. Overall MPP was reported by all eight studies.
Table S2 in File S1 illustrates the reported plantar pressures
according to plantar anatomical locations as well as the overall
plantar pressures from each study. Meta-analysis combining data
from eight studies (PPDFU n=238; DPN with no foot ulcer
history n= 409) suggested that patients with PPDFU had greater
overall MPP with moderate effect levels (standardised mean
difference 0.551, 95% CI 0.290–0.811; p#0.001). The heteroge-
neity between studies was moderate I2 = 46.2 (Figure 2).
Overall PTI. Three studies reported PTI values (Table S2 in
File S1). Meta-analysis combining data from all three studies
(PPDFU n=79; DPN with no foot ulcer history n= 54) suggested
that patients with PPDFU had greater overall PTI with moderate
effect levels (standardised mean difference 0.762, 95% CI 0.303–
1.221; p = 0.001). The heterogeneity between studies was moder-
ate I2 = 28.4 (Figure 3). As only three studies were found, sub-
group and sensitivity-analyses were not attempted.
Sensitivity and sub-group analyses
Meta-analysis combining data from three studies which
reported plantar pressure in active ulcer patients (PPDFU [present
ulcer only] n= 43; DPN with no foot ulcer history n= 74)
Figure 1. Search Results. Search results indicating total number of
identified records (2730) and the number of articles remaining after
duplicate removal (894) and the number of records excluded (827) and
the number of full text articles assessed for eligibility according to the
inclusion and exclusion criteria listed. This resulted in eight observa-
tional studies which were included in the meta-analysis.
doi:10.1371/journal.pone.0099050.g001
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suggested a non-significant difference for plantar pressure in
patients with active foot ulcers compared to DPN participants
without foot ulcers (Table 2). Furthermore, an analysis of three
studies using patients with a history of foot ulcers [previous
ulceration only] suggested that overall MPP was significantly
higher in those with a history of ulcers (n = 76) versus DPN without
a history of ulcers (n = 172), (standardised mean difference 0.467,
95% CI 0.181–0.753; p= 0.001) with low heterogeneity I2 = 3.6.
A sensitivity analysis was performed for overall MPP excluding
studies by Cavanagh et al. and Boulton et al. [33,34] as their SD
was estimated using linear regression (Table S2 in File S1). This
resulted in a small increase in effect size (standardised mean
difference 0.635, 95% CI 0.387–0.884; p#0.001), and reduction
in heterogeneity I2 = 31.4. Removal of the study by Rich et al. [38]
(Table 2) due to unit of analysis difference resulted in a small
increase in effect size but an increase in heterogeneity to
I2 = 50.76. Exclusion of the study by Stess et al. [35] (due to the
inclusion of foot amputees in the PPDFU group) created a minute
reduction in effect size and an increase in heterogeneity levels
(I2 = 53.9) (Table 2). The exclusion of two major studies potentially
causing heterogeneity (Stess et al. and Rich et al. [35,38]) resulted
in a small reduction in effect size and a substantial increase in
heterogeneity I2 = 58.9 (Table 2).
Secondary outcome measures
MPP at various plantar foot regions. As only two studies
reported on MPP at the rear foot, meta-analysis was not possible
[38,40]. This was also true with assessment made at the mid foot
[40,42]. However, six studies reported MPP measures at the fore
foot (Table S2 in File S1). Meta-analysis combining data from all
six studies (PPDFU n=211; DPN with no foot ulcer history
n= 339) suggested that patients with PPDFU had greater fore foot
MPP with moderate effect levels (standardised mean difference
0.635, 95% CI 0.387–0.884; p,0.001) (see Figure 4). The
heterogeneity between studies was moderate I2 = 31.4. When
excluding the study by Rich et al. due to differences in unit of
analysis, the heterogeneity dropped to I2 = 26.7, with a slight
increase in the overall effect (Table 2). The exclusion of the study
by Stess et al. resulted in a small reduction in effect size and an
increase in heterogeneity I2 = 44.9. The exclusion of the studies by
both Rich et al. and Stess et al. resulted in an increase in effect size
but also an increase in heterogeneity levels I2 = 42.5 (see Table 2).
PTI at various plantar foot regions. Meta-analysis was
only possible for fore foot PTI, as there were insufficient studies for
comparison of rear foot and mid foot PTI. Meta-analysis
combining data from three studies (PPDFU n=79; DPN with
no foot ulcer history n= 54) revealed higher fore foot PTI in
PPDFU patients (standardised mean difference 0.719, 95% CI
0.197–1.242; p= 0.007). The heterogeneity between studies was
high I2 = 44.4 (see Table 2).
Potential factors affecting plantar pressure
measurements in studies
We examined the effect of a number of potential confounding
factors including BMI, age and duration of DM on plantar
pressure at the aggregate level. Scatterplots of these variables were
constructed (Figure S2a, S2b, S2c).These analyses suggested that
higher BMI was associated with higher MPP in both groups,
Figure 2. Forest Plot. Forest Plot displaying the Overall Peak Plantar Pressure (MPP) between the PPDFU group (cases) and the DPN group
(control). Overall effect is represented by the coloured diagonal. Eight studies are included in total.
doi:10.1371/journal.pone.0099050.g002
Figure 3. Forest Plot. Forest Plot displaying the Overall Pressure Time Integral (PTI) between the PPDFU group(cases) and the DPN group(control).
Overall effect is represented by the coloured diagonal. Three studies are included in total.
doi:10.1371/journal.pone.0099050.g003
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which was consistent with previous studies [42,43]. It was not
possible to adjust our analyses for BMI since individual data was
not available. Therefore all inferences from aggregate data
included in this analysis should be made cautiously.
Discussion
One of the most detrimental complications of both Type 1 and
Type 2 DM is neuropathic foot ulceration [44]. As a majority of
Table 2. Meta analyses results.
Outcome measure Comparison
Number of
studies
Effect size
(95%-CI) p-value Heterogeneity assessment
Classic fail
safe N
Overall Peak Plantar
Pressure MPP [N/cm2]
PPDFU (n = 238) versus
DPN (n = 409)
8d 0.551 (0.290, 0.811) p,0.001 Q= 13.0; p = 0.072; I2 = 46.2 63
PPDFU (n = 211) versus
DPN (n = 339)
6d2 0.635 (0.387, 0.884) p,0.001 Q= 7.3; p = 0.200; I2 = 31.4 49
PPDFU (n = 185) versus
DPN (n = 282)
7a 0.553 (0.229, 0.876) p = 0.001 Q= 12.2; p = 0.058; I2 = 50.76 41
PPDFU (n = 43) versus
DPN (n = 74)
3c 0.394 (-0.237, 1.026) p = 0.221 Q= 4.8; p = 0.091; I2 = 58.3 /
PPDFU (n = 189) versus
DPN (n = 395)
7e 0.534 (0.235, 0.832) p,0.001 Q= 13.0; p = 0.043; I2 = 53.9 48
PPDFU (n = 136) versus
DPN (n = 268);
6f1 0.528 (0.143, 0.914) p = 0.007 Q= 12.1; p = 0.033; I2 = 58.9 29
PPDFU (n = 76) versus
DPN (n = 172)
3g 0.467 (0.181, 0.753) p = 0.001 Q= 2.1; P = 0.354; I2 = 3.6 4
Overall Peak Plantar
Pressure PTI [Ns/cm2]
PPDFU (n = 79) versus
DPN (n = 54)
3b 0.762 (0.303, 1.221) p = 0.001 Q= 2.8; p = 0.248; I2 = 28.4 9
Forefoot MPP [N/cm2] PPDFU (n = 211) versus
DPN (n = 339)
6 0.635 (0.387, 0.884) p,0.001 Q= 7.3; p = 0.200; I2 = 31.4 49
PPDFU (n = 158) versus
DPN (n = 212)
5a 0.692 (0.392, 0.992) p,0.001 Q= 5.5; p = 0.243; I2 = 26.7 31
PPDFU (n = 162) versus
DPN (n = 325)
5e 0.625 (0.323, 0.927) p,0.001 Q= 7.3; p = 0.123; I2 = 44.9 36
PPDFU (n = 109) versus
DPN (n = 198)
4f2 0.670 (0.273, 1.066) p = 0.001 Q= 5.2; p = 0.157; I2 = 42.5 21
Forefoot PTI [Ns/cm2] PPDFU (n = 79) versus
DPN (n = 54)
3b 0.719 (0.197, 1.242) p = 0.007 Q= 3.6; p = 0.165; I2 = 44.4 8
Legend: Random effects model meta-analyses. Effect size is standardised difference of mean values calculated as (DPN – PPDFU). Hence a negative result implies smaller
values for DPN.
aRich et al. (2000) excluded because of issues with unit of analysis;
bStudies included Bacarin, Sauseng and Stess;
cAnalysis of studies with 100% active ulcer group [active ulcer only] (Cavanagh et al Sauseng et al and Brash et al);
dAll studies (n = 8) including Cavanagh and Boulton with SD estimated from linear regression;
d2Excluding Cavanagh and Boulton with SD estimated from linear regression;
eStess et al (1997) excluded due to high level of heterogeneity and inclusion of amputees;
f1Rich et al and Stess et al excluded due to reasons given above;
f2Rich et al and Stess et al excluded due to reasons given above;
gAnalysis with history of ulcers only [excluding active ulceration] (Bacarin et al, Boulton et al and Rich et al).
doi:10.1371/journal.pone.0099050.t002
Figure 4. Forest Plot. Forest Plot displaying the Fore Foot Peak Plantar Pressure (MPP) between PPDFU group (cases) and DPN group (control).
Overall effect is represented by the coloured diagonal. Six studies are included in total.
doi:10.1371/journal.pone.0099050.g004
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neuropathic foot ulcers are likely to form due to mechanical
loading on the insensate foot during locomotion, plantar pressure
is an important biomechanical consideration in the investigation of
the neuropathic foot [14,45,46,47]. This meta-analysis identified
that overall MPP was higher in DPN patients with a history of foot
ulceration compared to those without a history of foot ulceration,
although there was moderate between study heterogeneity. Some
patients included in this meta-analysis had active foot ulcers while
others had a past history of foot ulceration at the time of
assessment. Subgroup analyses revealed only those with previous
ulceration, and not active ulceration, had significantly greater
plantar pressures compared to those with DPN alone, with low
between study heterogeneity. The sample sizes for the sub-group
analyses were however small. PTI was significantly higher in DPN
patients with a history of foot ulceration. Heterogeneity between
studies for this finding was moderate. Sensitivity analyses suggested
that heterogeneity between studies assessing MPP was contributed
to by a number of factors including study quality and reporting.
Secondary outcome data suggested that patients with PPDFU
had higher plantar pressures at the fore foot with moderate
between study heterogeneity. Further analysis involving those with
previous ulceration only and in those with active ulceration only
was not possible. Subgroup analysis was limited by the
demographic information available in studies and the overall
number of studies. Hence this could not be carried out separately
for Type 1 and Type 2 DM, age, BMI, or DM duration. A
sensitivity analysis suggested that heterogeneity was reduced by
excluding studies in which the SD had to be estimated [33,34].
One study included patients with minor pedal amputations which
have been reported to increase plantar pressures and may have
confounded their assessments [48]. Therefore future plantar
pressure studies are recommended to adjust for the role of
amputation or to include those with a previous minor amputation
as a standalone group to determine plantar pressures in this end-
stage DPN group. Regardless of these limitation, the finding of
elevated fore foot plantar pressures in patients with PPDFU are
consistent with the fact that the majority of DFU are found in the
forefoot region [49]. PTI assessed at the forefoot was also greater
in patients with PPPDFU. Sensitivity and sub-group analyses were
unable to be performed due to the low number of available studies.
Hence further studies are needed to assess the plantar pressure
characteristics of the different anatomical areas of the foot in active
and previous foot ulcer populations.
The MPP of patients with active DFUs was not significantly
higher than controls; yet, the MPP of patients with previous DFUs
was significantly higher. The between study heterogeneity of
factors such as different lengths of time since ulceration and
different characteristics of DFUs included in the individual studies
may have contributed to this result. Small sample sizes were also
present which could have contributed to the non-significant result
in the active DFU group. Bacarin et al. included only patients who
had a previous foot ulcer, and no active ulceration, within the 12
months preceding their examination and this was one of the few
studies which reported no difference in plantar pressures between
the two groups [40]. However, Sauseng and colleagues utilised
active ulcer patients who had a history of at least one ulcer on the
contralateral foot [36]. Armstrong et al. only included patients
who had an existing or recently healed (,4 weeks) plantar foot
ulcer, however the relative number of patients in each category
were not defined and this study was unable to be included in
subgroup analyses [23]. Boulton et al. included participants with a
history of plantar ulcers with neuropathy and painful bilateral
symptoms (paraesthesia, burning, and cramps) and absent ankle
jerks for at least twelve months preceding the study [33]. For Rich
et al. we were unable to distinguish demographic characteristics of
the PPDFU and DPN groups from the reported aggregate data
and the authors were unable to provide this information when
requested [38]. Brash et al. studied feet which were ulcerated on
the plantar surface of the first metatarsal head up to 2 years prior
to the study [41]. Stess et al. included 67% of patients with active
ulcers and 26% of those with active ulcers had some form of lower
extremity digital or ray amputation [35]. Ideally, a more
homogenous group of DFU participants are needed to confirm
plantar pressure changes which accompany previous and active
ulceration in those with DPN. Adopting international standard
methods for the non-invasive diagnoses of sensory neuropathy may
increase homogeneity of future studies and could have improved
the homogeneity of this meta-analysis. For example, as identified
in our study, there are currently a range of non-invasive methods
for diagnosing DPN; however, a more anatomically global tool
such as a pressure specific sensory device (PSSD) may provide a
more standardised method for diagnosing sensory neuropathy
[50]. PSSD has been validated as a non-invasive method to detect
sensory neuropathy in a variety of diverse anatomical locations
including the foot [50,51], breast [52] and tongue [53].
Recommendations to standardise non-invasive methods that apply
to a broad range of anatomical locations may assist homogeneity
of a wide variety of studies in the future.
Although heterogeneity is evident between studies, the results of
this meta-analysis seems to suggest that those with DPN and
previous ulceration demonstrate an elevation in plantar pressure
compared to those with DPN and no ulceration history. However,
those with DPN and active ulceration do not demonstrate an
elevation in plantar pressures compared to those with DPN and no
ulceration history. It could be hypothesised that even though those
with active foot ulcers are insensate, they may still alter their
movement characteristics to a ‘guarded gait strategy’ during
barefoot gait to compensate for the presence of their active ulcer,
which in turn may result in a reduction in plantar pressures during
the active ulcer phase. This highlights the possibility of an
alteration in the gait strategy of these individuals during active
ulceration which is contrary to previous findings in the area [12–
14]. Furthermore, it could be postulated that following ulcer
healing, it is likely that this guarded gait strategy diminishes over
time and plantar pressures return to the high levels that may have
either initiated the active ulcer or were experienced during the
phase of any previously healed ulcer. This hypothesis would
support studies indicating that identifying a plantar pressure cut-
off value to predict ulceration is plausible. Although this theory is
consistent with the meta-analysis findings, the current evidence is
insufficient to substantiate this hypothesis.
Despite limitations, this meta-analysis supplements the body of
research in the area of plantar pressure in patients with DPN and
offers evidence for differences in plantar pressure between those
with DPN and a history of DFU compared to those with DPN
without an ulcer history. This meta-analysis has a number of key
limitations including the significant between study heterogeneity,
small sample sizes and the lack of available studies. It remains
unclear whether screening patients for elevated plantar pressures
improves patient outcomes.
Conclusion
Whilst the potential feasibility of using plantar pressure as a
screening tool for ulceration remains viable, more explicit studies,
including longitudinal studies involving better defined patient
groups are needed to clarify the extent of plantar pressure difference
throughout the sequelae of peripheral diabetic complications.
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Furthermore, while this meta-analysis occurred at an aggregate
level, more prospective studies are needed to investigate the role of
factors such as BMI, age and DM duration which could potentially
influence plantar pressures in those with a history of foot ulcers and
active foot ulcers. The use of plantar pressure as a screening tool
could be supplemented by further understanding the influence that
plantar pressures have in foot ulcer pathogenesis and healing.
Supporting Information
Figure S1 Search terms. Search Terms utilised for database
searching.
(TIF)
Figure S2 Scatterplots of associated variables affecting
plantar pressure. The scatterplots display potential clinical
variables influencing the differences in plantar pressure between
PPDFU and DPN, at the aggregate level. These included [a]
diabetes duration (years), [b] body mass index (BMI) and [c]
chronological age.
(TIF)
Checklist S1 PRISMA guidelines checklist.
(PDF)
Checklist S2 MOOSE guidelines checklist.
(DOCX)
File S1 Contains two tables Table S1 (Assessment of
methodological quality of studies) and Table S2 (Plantar
pressure distribution). Table S1. Assessment of methodolog-
ical quality of studies. Methodological quality of studies as assessed
independently by (EP) and (PL) using a modified quality
assessment tool. For the scoring system, 1= (P) partially, 0 =
(N) no and 2= (Y) yes. The Total score was out of a possible 50.
Mean scores were the average of the two individual scores
rounded down to the nearest integer. The mean scores in
(brackets) indicate mean scores for the assessment of participant
and plantar pressure related methodology out of a total of 22
(Q16-Q25). *PVD= Peripheral Vascular Disease. a These were
the subject relevant questions (regarding participant specific
characteristics and methods of plantar pressure measurement)
which were assessed as suitable by a panel of experts and were
added to the quality assessment tool; The identification and
quantification of DPN-How was neuropathy diagnosed and
quantified? The identification or exclusion of PVD in participants-
Was PVD accounted for appropriately? The identification of type
of diabetes and diabetes duration in participants- These are
important considerations in diabetes foot ulcer pathogenesis.
Whether the glycaemic control of the participants’ was reported-
This gives guidance as to the level of glycemic control of
participants. Whether the foot structure of participants was
reported- An important consideration in the assessment of plantar
pressure. Whether a history of diabetes foot ulceration or current
diabetes foot ulceration was checked in all participants? Whether
the methods pertaining to plantar pressure capture were reported;
this included the general methods, number of steps, verbal
instructions and number of walking trials- This was to identify
the feasibility for reproducibility of the study using appropriate
methods. Table S2: Plantar pressure distribution. Report-
ed foot plantar pressures and pressure time integrals normalised to
body weight (mean) and (SD). Where multiple results were
reported, the highest value in the PPDFU group was used with the
corresponding value in the control group. For overall peak
pressure, the highest reported MPP and PTI was used, irrespective
of location. aThis study did not report S D therefore the S D were
estimated, the values in brackets indicate estimated S D (please see
manuscript for details of how these were approximated). bThis
study did not report Mean and s.d and in place (IQR) was
reported. cThis study reported findings as number of feet instead of
patients. dThis study reported absolute values for MPP but not for
PTI, therefore the PTI values were estimated from graphs
provided.
(DOCX)
Acknowledgments
The authors would like to acknowledge the staff from The Townsville
Hospital library, especially Mrs. Bronia Renison and staff from the James
Cook University library for their assistance with literature searches and
manuscript retrieval. Authors would also like to thank Miss. Danielle
Moore from the Vascular Biology Unit for her assistance with manuscript
de-identification for quality assessment.
Author Contributions
Conceived and designed the experiments: MEF RGC EP PAL MC KSS
PB JG. Performed the experiments: MEF PB. Analyzed the data: MEF MC
PB JG. Contributed to the writing of the manuscript: MEF RGC EP PAL
MC KSS PB JG. Was the primary author and designed the protocol,
extracted data and wrote the manuscript for publication: MEF. Was the
subject expert on plantar pressure and assisted in selection of studies for
inclusion: RC. Conducted the quality assessment and assisted with the
editing of the manuscript: EP PAL. Provided expertise on methods, assisted
with assessing study inclusion and write-up of the manuscript: MC.
Clinicians and subject experts on diabetes and research methods and
assisted with preparation and planning of methods, editing the final
publication and critical input regarding analyses: KSS JG. Was the
statistician and subject expert on meta-analysis and carried out all analysis
and graphical illustrations: PB.
References
1. Jeffcoate WJ, Harding KG (2003) Diabetic foot ulcers. The Lancet 361: 1545–
1551.
2. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J (2005) The global
burden of diabetic foot disease. Lancet 366: 1719–1724.
3. Singh N, Armstrong DG, Lipsky BA (2005) Preventing foot ulcers in patients
with diabetes. Journal of the American Medical Association 293: 217–228.
4. Gonzalez R, Pedro T, Real JT, Martinez-Hervas S, Abellan MR, et al. (2010)
Plasma homocysteine levels are associated with ulceration of the foot in patients
with type 2 diabetes mellitus. Diabetes/metabolism research and reviews 26:
115–120.
5. Clayton WJ, Elasy TA (2009) A Review of the Pathophysiology, Classification,
and Treatment of Foot Ulcers in Diabetic Patients. Journal of Clinical Diabetes
27: 52–58.
6. Shenoy AM (2012) Guidelines in practice: Treatment of painful diabetic
neuropathy. Continuum Lifelong Learning in Neurology 18: 192–198.
7. Cook J, Simonson D (2012) Epidemiology and Health Care Cost of Diabetic
Foot Problems. In: Veves A, Giurini JM, LoGerfo FW, editors. The Diabetic
Foot.Online: Springer. pp.17–32. Available: http://link.springer.com/book/10.
1007%2F978-1-61779-791-0. Accessed 18/10/2013
8. Boulton AJ (2004) The diabetic foot: From art to science. The 18th Camillo
Golgi lecture. Diabetologia 47: 1343–1353.
9. Lazzarini PA, Gurr JM, Rogers JR, Schox A, Bergin SM (2012) Diabetes foot
disease: the Cinderella of Australian diabetes management? J Foot Ankle Res 5:
24.
10. Cox PS, Williams SK, Weaver SR (2011) Life after lower extremity amputation
in diabetics. The West Indian Medical Journal 60: 536–540.
11. Garcia-Morales E, Lazaro-Martinez JL, Martinez-Hernandez D, Aragon-
Sanchez J, Beneit-Montesinos JV, et al. (2011) Impact of diabetic foot related
complications on the Health Related Quality of Life (HRQol) of patients-a
regional study in Spain. The international Journal of Lower Extremity Wounds
10: 6–11.
12. Savelberg HHCM, Schaper NC, Meijer K (2009) The vertical component of the
ground reaction force does not reflect horizontal braking or acceleration per se.
Clinical Biomechanics 24: 527–528.
Meta Analysis of Plantar Pressure in Diabetic Peripheral Neuropathy
PLOS ONE | www.plosone.org 9 June 2014 | Volume 9 | Issue 6 | e99050
13. Cavanagh P, Ulbrecht J, Caputo G (1996) Biomechanical aspects of diabetic foot
disease: aetiology, treatment, and prevention. Diabet Med 13: S17–22.
14. Veves A, Murray HJ, Young MJ, Boulton AJ (1992) The risk of foot ulceration in
diabetic patients with high foot pressure: A prospective study. Diabetologia 35:
660–663.
15. Melai T, Ijzerman TH, Schaper NC, de Lange TLH, Willems PJB, et al. (2011)
Calculation of plantar pressure time integral, an alternative approach. Gait and
Posture 34: 379–383.
16. Fernando M, Crowther R, Lazzarini P, Sangla K, Cunningham M, et al. (2013)
Biomechanical characteristics of peripheral diabetic neuropathy: A systematic
review and meta-analysis of findings from the gait cycle, muscle activity and
dynamic barefoot plantar pressure. Clinical Biomechanics 28: 831–45.
17. Bus SA, Waaijman R, Arts M, Manning H (2009) The efficacy of a removable
vacuum-cushioned cast replacement system in reducing plantar forefoot
pressures in diabetic patients. Clinical Biomechanics 24: 459–464.
18. Viswanathan V, Madhavan S, Gnanasundaram S, Gopalakrishna G, Nath Das
B, et al. (2004) Effectiveness of Different Types of Footwear Insoles for the
Diabetic Neuropathic Foot: A follow-up study. Diabetes care 27: 474–477.
19. van Deursen R (2008) Footwear for the neuropathic patient: Offloading and
stability. Diabetes/metabolism research and reviews 24: S96–S100.
20. Paton J, Bruce G, Jones R, Stenhouse E (2011) Effectiveness of insoles used for
the prevention of ulceration in the neuropathic diabetic foot: a systematic review.
J Diabetes Complications 25: 52–62.
21. Coles S (2008) Footwear and offloading for patients with diabetes. Nurs Times
104: 40, 42–43.
22. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG (1998)
Practical criteria for screening patients at high risk for diabetic foot ulceration.
Arch Intern Med 158: 157–162.
23. Armstrong D, Peters E, Athanasiou K, Lavery L (1998) Is there a critical level of
plantar foot pressure to identify patients at risk for neuropathic foot ulceration?
J Foot Ankle Surg 37: 303–307.
24. Lavery LA, Armstrong DG, Wunderlich RP, Tredwell J, Boulton AJ (2003)
Predictive value of foot pressure assessment as part of a population-based
diabetes disease management program. Diabetes care 26: 1069–1073.
25. Crawford F, Inkster M, Kleijnen J, Fahey T (2007) Predicting foot ulcers in
patients with diabetes: A systematic review and meta-analysis. QJM 100: 65–86.
26. Chevalier TL, Hodgins H, Chockalingam N (2010) Plantar pressure measure-
ments using an in-shoe system and a pressure platform: A comparison. Gait &
Posture 31: 397–399.
27. Sanderson S, Tatt ID, Higgins JP (2007) Tools for assessing quality and
susceptibility to bias in observational studies in epidemiology: a systematic review
and annotated bibliography. Int J Epidemiol 36: 666–676.
28. Critical Appraisal Skills Programme C (2010) Critical Appraisal Skills
Programme: making sense of evidence about clinical effectiveness: 11 questions
to help you make sense of cohort study. Available: http://wwwcasp-uknet/wp-
content/uploads/2011/11/CASP-Cohort-Study-Checklist-310513pdf. Ac-
cessed: 14th November 2013.
29. Critical Appraisal Skills Programme C (2010) Critical Appraisal Skills
Programme: making sense of evidence about clinical effectiveness: 11 questions
to help you make sense of case control study. Available: http://wwwcasp-uknet/
wp-content/uploads/2011/11/CASP-Case-Control-Study-Checklist-
310513pdf. Accessed: 10th November 2013.
30. Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M (2003)
Reliability of the PEDro scale for rating quality of randomized controlled trials.
Physical therapy 83: 713–721.
31. Stroup DF, Berlin JA, Morton SC (2000) Meta-analysis of observational studies
in epidemiology: A proposal for reporting. JAMA: the journal of the American
Medical Association 283: 2008–2012.
32. Cohen J (1988) Statistical Power analysis of the behavioural sciences. United
States: Lawrence Erlbaum Associates Inc. 474 p.
33. Boulton AJ, Hardisty CA, Betts RP, Franks CI, Worth RC, et al. (1983)
Dynamic foot pressure and other studies as diagnostic and management aids in
diabetic neuropathy. Diabetes Care 6: 26–33.
34. Cavanagh PR, Sims DS, Sanders LJ (1991) Body mass is a poor predictor of
peak plantar pressure in diabetic men. Diabetes care 14: 750–755.
35. Stess RM, Jensen SR, Mirmiran R (1997) The role of dynamic plantar pressures
in diabetic foot ulcers. Diabetes care 20: 855–858.
36. Sauseng S, Ka¨stenbauer T, Sokol G, Irsigler K (1999) Estimation of risk for
plantar foot ulceration in diabetic patients with neuropathy. Diabetes, Nutrition
and Metabolism - Clinical and Experimental 12: 189–193.
37. McGough JJ, Faraone SV (2009) Estimating the size of treatment effects: moving
beyond p values. Psychiatry (Edgmont (Pa: Township)) 6: 21–29.
38. Rich J, Veves A (2000) Forefoot and Rearfoot Plantar Pressures in Diabetic
Patients: Correlation to Foot Ulceration. Wounds 12: 82–87.
39. Persaud R (1996) Misleading meta-analysis. "Fail safe N" is a useful
mathematical measure of the stability of results. BMJ 312: 125.
40. Bacarin TA, Sacco IC, Hennig EM (2009) Plantar pressure distribution patterns
during gait in diabetic neuropathy patients with a history of foot ulcers. Clinics
(Sao Paulo, Brazil) 64: 113–120.
41. Brash PD, Foster JE, Vennart W, Daw J, Tooke JE (1996) Magnetic resonance
imaging reveals micro-haemorrhage in the feet of diabetic patients with a history
of ulceration. Diabet Med 13: 973–978.
42. Shen J, Liu F, Zeng H, Wang J, Zhao JG, et al. (2012) Vibrating perception
threshold and body mass index are associated with abnormal foot plantar
pressure in type 2 diabetes outpatients. Diabetes Technol Ther 14: 1053–1059.
43. Sugimoto K, Yasujima M, Yagihashi S (2008) Role of advanced glycation end
products in diabetic neuropathy. Curr Pharm Des 14: 953–961.
44. Boulton AJ (2005) Management of Diabetic Peripheral Neuropathy. Clinical
Diabetes 23: 9–15.
45. Masson EA, Hay EM, Stockley I, Veves A, Betts RP, et al. (1989) Abnormal foot
pressures alone may not cause ulceration. Diabetic Medicine 6: 426–428.
46. Cavanagh P, Ulbrecht J, Caputo G (2000) New developments in the
biomechanics of the diabetic foot. Diabetes/metabolism research and reviews
16: S6–S10.
47. van Schie CH (2005) A review of the biomechanics of the diabetic foot. The
international journal of lower extremity wounds 4: 160–170.
48. Armstrong DG, Lavery LA (1998) Plantar pressures are higher in diabetic
patients following partial foot amputation. Ostomy Wound Manage 44: 30–32.
49. Altindas M, Kilic A, Cinar C, Bingol UA, Ozturk G (2011) The Epidemiology of
Foot Wounds in Patients with Diabetes: A Description of 600 Consecutive
Patients in Turkey. The Journal of Foot & Ankle Surgery 50: 146–152.
50. Wood WA, Wood MA, Werter SA, Menn JJ, Hamilton SA, et al. (2005) Testing
for loss of protective sensation in patients with foot ulceration: a cross-sectional
study. J Am Podiatr Med Assoc 95: 469–474.
51. Ferreira MC, Rodrigues L, Fels K (2004) New method for evaluation of
cutaneous sensibility in diabetic feet: preliminary report. Rev Hosp Clin Fac
Med Sao Paulo 59: 286–290.
52. Longo B, Campanale A, Farcomeni A, Santanelli F (2013) Long-term sensory
recovery of nipple-areola complex following superolateral pedicled reduction
mammaplasty. Plast Reconstr Surg 132: 735–742.
53. Longo B, Pagnoni M, Ferri G, Morello R, Santanelli F (2013) The mushroom-
shaped anterolateral thigh perforator flap for subtotal tongue reconstruction.
Plast Reconstr Surg 132: 656–665.
Meta Analysis of Plantar Pressure in Diabetic Peripheral Neuropathy
PLOS ONE | www.plosone.org 10 June 2014 | Volume 9 | Issue 6 | e99050
